Press releases | WebDisclosure

Basculer en Français

10372	Companies
216173	Keywords
145882	Articles
114461	Press releases

Home
Press releases

PRESS RELEASE

published on 05/22/2025 at 06:00, 11 months 19 days ago

GameSquare's Stream Hatchet Publishes Influencer Marketing Guide
Stream Hatchet, a GameSquare subsidiary, releases an influencer marketing guide to help creators reach live streaming audiences, capitalizing on the growing market. Learn more: Expert Influencer Marketing Tips - Free Download

Influencer Marketing Stream Hatchet Live Streaming Campaigns Marketing Guide
PRESS RELEASE

published on 05/22/2025 at 04:34, 11 months 19 days ago

EQS-Adhoc: Dexus Finance Pty Limited: Update on the Dexus Bloc interest in APAC
Dexus Finance Pty Limited provides an update on the Dexus Bloc interest in Australia Pacific Airports Corporation, including the injunction obtained against APAC to protect Dexus Bloc Shareholders' interests

Shareholders Dexus Finance Pty Limited APAC Injunction Dexus Bloc
PRESS RELEASE

published on 05/22/2025 at 03:07, 11 months 19 days ago

Drilling Begins on High-Grade Gold & Silver Targets
Barton Gold Holdings Limited releases announcement regarding gold production targets and mineral resources in South Australia

ASX Gold Production Mineral Resources Barton Gold Holdings Limited South Australia
PRESS RELEASE

published on 05/22/2025 at 01:15, 11 months 19 days ago

Communiqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologie
Sanofi annonce l'acquisition de Vigil Neuroscience, Inc. pour développer un médicament expérimental contre la maladie d'Alzheimer. Renforcement du portefeuille en neurologie

Acquisition Maladie D'Alzheimer Sanofi Neurologie Vigil Neuroscience
PRESS RELEASE

published on 05/22/2025 at 01:15, 11 months 19 days ago

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
Sanofi acquires Vigil Neuroscience to enhance neurology pipeline with an investigational medicine for Alzheimer's disease. The acquisition includes VG-3927, a small molecule TREM2 agonist

Alzheimer's Disease Sanofi Neurology Vigil Neuroscience VG-3927
PRESS RELEASE

published on 05/21/2025 at 23:00, 11 months 19 days ago

Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results
Medicure Inc. reports Q1 2025 results with $5.5M net revenue, elects directors, and details financial performance. AGGRASTAT and ZYPITAMAG sales analyzed

Medicure Inc. Net Revenue AGGRASTAT ZYPITAMAG Q1 2025 Results
PRESS RELEASE

published on 05/21/2025 at 22:18, 11 months 19 days ago

ALT5 Sigma Corporation Announces Record Date for Alyea Therapeutics Corporation Transaction
ALT5 Sigma Corporation announces record date for separation of healthcare assets Alyea Therapeutics Corporation. Details of transaction to be announced later this year

Fintech Blockchain-powered Technologies ALT5 Sigma Corporation Healthcare Assets Separation Alyea Therapeutics Corporation
PRESS RELEASE

published on 05/21/2025 at 22:15, 11 months 19 days ago

ALT5 Sigma Corporation Announces Record Date for Alyea Therapeutics Corporation Transaction
ALT5 Sigma Corporation announces record date for separation of healthcare assets, Alyea Therapeutics Corp, to focus on unique business needs

Record Date Fintech ALT5 Sigma Corporation Healthcare Assets Alyea Therapeutics Corp
PRESS RELEASE

published on 05/21/2025 at 22:15, 11 months 19 days ago

Nanobiotix Provides First Quarter 2025 Operational and Financial Update
Nanobiotix provides operational and financial update for Q1 2025, including CONVERGE study dosing, financial strengthening, and €39.8M cash reserves as of March 31, 2025

Operational Update Financial Update Cash Reserves NANOBIOTIX CONVERGE Study
PRESS RELEASE

published on 05/21/2025 at 22:15, 11 months 19 days ago

Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du premier trimestre 2025
Nanobiotix annonce ses progrès opérationnels et sa trésorerie pour le premier trimestre 2025, avec un renforcement financier et des avancées dans le traitement du cancer du poumon

Trésorerie Études Cliniques NANOBIOTIX Cancer Du Poumon JNJ-1900

Accesswire

Published on 05/09/2026 at 01:55, 1 day 4 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 4 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 4 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 6 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 7 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/09/2026 at 19:05, 11 hours 2 minutes ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 9 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 10 hours ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 11 hours ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 1 day 11 hours ago

Designated Person Notification

Les Echos

Published on 05/07/2026 at 19:15, 2 days 10 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 10 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 11 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 11 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 11 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE